Herantis Pharma Oyj (HEL:HRTIS)
Finland · Delayed Price · Currency is EUR 2.480
+0.180 (7.83%)
Oct 10, 2025, 12:57 PM EET
Herantis Pharma Oyj Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
55.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orion Oyj | 1.68B |
| Terveystalo Oyj | 1.32B |
| Revenio Group Oyj | 107.22M |
| Pihlajalinna Oyj | 699.52M |
| Oriola Oyj | 1.81B |
| Nightingale Health Oyj | 4.69M |
| Nexstim | 11.63M |
| Nanoform Finland Oyj | 3.95M |
Herantis Pharma Oyj News
- 1 day ago - Herantis Pharma Oyj (HRPMF) Announcement of Positive Topline Results from Phase 1b Trial of HER-096 Transcript - Seeking Alpha
- 1 day ago - Herantis Pharma Oyj - Special Call - Seeking Alpha